Nikko Asset Management Americas’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
CL
RWMG
HH
Nikko Asset Management Americas's BNR Position: Q1 2026 in Review
Nikko Asset Management Americas reduced its Burning Rock Biotech (BNR) stake by 5.3% in Q1 2026, selling an estimated $43.7K and leaving 30,137 shares worth $488K. The position accounts for 0.01% of the portfolio, ranked #179.
Nikko Asset Management Americas first reported a position in BNR in Q4 2020 and has held it in 22 quarters since. The position peaked at $23.2M in Q1 2021. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.
- Nikko Asset Management Americas held 30,137 shares of Burning Rock Biotech worth $488K as of Q1 2026.
- Nikko Asset Management Americas sold 1,670 Burning Rock Biotech shares in Q1 2026, an estimated $43.7K.
- Burning Rock Biotech made up 0.01% of Nikko Asset Management Americas's portfolio in Q1 2026, its #179 holding.
- Nikko Asset Management Americas first reported a position in Burning Rock Biotech in Q4 2020 and has held it in 22 quarters since.
- Nikko Asset Management Americas's Burning Rock Biotech position peaked at $23.2M in Q1 2021.
- 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.
Based on Nikko Asset Management Americas's 13F filing for Q1 2026, filed 7 May 2026.